{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:59:36Z","timestamp":1791921576223,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017065","name":"Rogel Cancer Center, University of Michigan","doi-asserted-by":"publisher","award":["R37-CA-273138-01"],"award-info":[{"award-number":["R37-CA-273138-01"]}],"id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017065","name":"Rogel Cancer Center, University of Michigan","doi-asserted-by":"publisher","award":["1-R01-CA-208335-01-A1"],"award-info":[{"award-number":["1-R01-CA-208335-01-A1"]}],"id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017065","name":"Rogel Cancer Center, University of Michigan","doi-asserted-by":"publisher","award":["5-R33-CA-202867-02"],"award-info":[{"award-number":["5-R33-CA-202867-02"]}],"id":[{"id":"10.13039\/100017065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.neo.2024.101036","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T01:39:36Z","timestamp":1724377176000},"page":"101036","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-616X","authenticated-orcid":false,"given":"Zeqi","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7040-1641","authenticated-orcid":false,"given":"Molly","family":"Kozminsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1633-9092","authenticated-orcid":false,"given":"Kathleen C.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2015-2928","authenticated-orcid":false,"given":"Luke J.","family":"Broses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3998-6532","authenticated-orcid":false,"given":"Marian L.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Patsalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Tagett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoping","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Blumberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachery R.","family":"Reichert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia D.","family":"Merajver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron M.","family":"Udager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip L.","family":"Palmbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunitha","family":"Nagrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7774-2326","authenticated-orcid":false,"given":"Mark L.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2024.101036_bib0001","unstructured":"Anon. World cancer research day 2023: the bladder cancer epidemiology and early detection in Africa (BEED) study [Internet]. [cited 2024 Jan 16]. Available from: https:\/\/www.iarc.who.int\/cancer-type\/bladder-cancer."},{"key":"10.1016\/j.neo.2024.101036_bib0002","unstructured":"Anon. Institute NC. Surveillance, epidemiology, and end results (SEER) program SEER*Stat database: cancer stat facts: bladder cancer [Internet]. 2022. Available from: www.seer.cancer.gov."},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0003","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.neo.2024.101036_bib0004","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","article-title":"Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes","volume":"17","author":"Meeks","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.neo.2024.101036_bib0005","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0006","first-page":"566","article-title":"PD-L1 expression in circulating tumor cells increases during radio(chemo)therapy and indicates poor prognosis in non-small","volume":"9","author":"Wang","year":"2019","journal-title":"Cell Lung Cancer Sci Rep."},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0007","doi-asserted-by":"crossref","first-page":"13441","DOI":"10.1038\/s41598-021-92876-8","article-title":"Circulating tumour cells at baseline and late phase of treatment provide prognostic value in breast cancer","volume":"11","author":"Pang","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neo.2024.101036_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9091179","article-title":"Clinical relevance of circulating tumor cells in prostate cancer management","volume":"9","author":"Cie\u015blikowski","year":"2021","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.neo.2024.101036_bib0009","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/annonc\/mdr619","article-title":"Prognostic value of circulating tumor cellsin nonmuscle invasive bladder cancer: Acellsearch analysis","volume":"23","author":"Gazzaniga","year":"2012","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.neo.2024.101036_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/BLC-160069","article-title":"Clinical significance of early changes in circulating tumor cells from patients receiving first-line cisplatin-based chemotherapy for metastatic urothelial carcinoma","volume":"2","author":"Fina","year":"2016","journal-title":"Bladder Cancer"},{"issue":"5","key":"10.1016\/j.neo.2024.101036_bib0011","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tips.2022.02.005","article-title":"Circulating tumor cells in precision medicine: challenges and opportunities","volume":"43","author":"Rupp","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neo.2024.101036_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/s20071875","article-title":"Microfluidics and nanomaterial-based technologies for circulating tumor cell isolation and detection","volume":"20","author":"Cheng","year":"2020","journal-title":"Sensors"},{"issue":"10","key":"10.1016\/j.neo.2024.101036_bib0013","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nnano.2013.194","article-title":"Sensitive capture of circulating tumour cells by functionalized graphene oxide nanosheets","volume":"8","author":"Yoon","year":"2013","journal-title":"Nat. Nanotechnol."},{"issue":"7173","key":"10.1016\/j.neo.2024.101036_bib0014","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nature06385","article-title":"Isolation of rare circulating tumour cells in cancer patients by microchip technology","volume":"450","author":"Nagrath","year":"2007","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.neo.2024.101036_bib0015","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.201800278","article-title":"Characterizing circulating tumor cells isolated from metastatic breast cancer patients using graphene oxide based microfluidic assay","volume":"3","author":"Kim","year":"2019","journal-title":"Adv. Biosyst."},{"issue":"2","key":"10.1016\/j.neo.2024.101036_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201801254","article-title":"Detection of CTC clusters and a dedifferentiated RNA-expression survival signature in prostate cancer","volume":"6","author":"Kozminsky","year":"2019","journal-title":"Adv. Sci."},{"issue":"6","key":"10.1016\/j.neo.2024.101036_bib0017","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.eururo.2018.06.047","article-title":"Targeted DNA and RNA sequencing of paired urothelial and squamous bladder cancers reveals discordant genomic and transcriptomic events and unique therapeutic implications","volume":"74","author":"Hovelson","year":"2018","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0018","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/0008-5472.CAN-16-1656","article-title":"HER2 and EGFR overexpression support metastatic progression of prostate cancer to bone","volume":"77","author":"Day","year":"2017","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.neo.2024.101036_bib0019","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.eururo.2012.01.017","article-title":"Prognostic role and HER2 expression of circulating tumor cells in peripheral blood of patients prior to radical cystectomy: a prospective study","volume":"61","author":"Rink","year":"2012","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.neo.2024.101036_bib0020","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-12-3349","article-title":"HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab","volume":"73","author":"Ithimakin","year":"2013","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0021","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1186\/s12885-016-2758-3","article-title":"Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients","volume":"16","author":"Anantharaman","year":"2016","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.neo.2024.101036_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150138","article-title":"ADAM15 is functionally associated with the metastatic progression of human bladder cancer","volume":"11","author":"Lorenzatti Hiles","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.neo.2024.101036_bib0023","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1158\/0008-5472.CAN-07-2432","article-title":"ADAM15 supports prostate cancer metastasis by modulating tumor cell\u2013endothelial cell interaction","volume":"68","author":"Najy","year":"2008","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.neo.2024.101036_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aat7828","article-title":"Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival","volume":"4","author":"Gast","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.neo.2024.101036_bib0025","first-page":"7178","article-title":"Overexpression of epidermal growth factor receptor (EGFR) and HER-2 in bladder carcinoma and its association with patients\u2019 clinical features","volume":"24","author":"Li","year":"2018","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0026","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3390\/cimb46010050","article-title":"Molecular profiling of circulating tumour cells and circulating tumour DNA: complementary insights from a single blood sample utilising the parsortix\u00ae system","volume":"46","author":"Wishart","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"5","key":"10.1016\/j.neo.2024.101036_bib0027","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s11255-020-02725-2","article-title":"Clear cell carcinoma of the urinary bladder: a systematic review","volume":"53","author":"Chan","year":"2021","journal-title":"Int. Urol. Nephrol."},{"issue":"7","key":"10.1016\/j.neo.2024.101036_bib0028","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1158\/2159-8290.CD-11-0215","article-title":"A novel platform for detection of CK+ and CK\u2212 CTCs","volume":"1","author":"Pecot","year":"2011","journal-title":"Cancer Discov."},{"issue":"4","key":"10.1016\/j.neo.2024.101036_bib0029","first-page":"278","article-title":"Prediction of recurrence and progression in patients with T1G3 bladder cancer by gene expression of circulating tumor cells","volume":"38","author":"Awadalla","year":"2020","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"issue":"5","key":"10.1016\/j.neo.2024.101036_bib0030","first-page":"1199","article-title":"Tenascin C and epidermal growth factor receptor as markers of circulating tumoral cells in bladder and colon cancer","volume":"14","author":"Gazzaniga","year":"2005","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.neo.2024.101036_bib0031","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/annonc\/mdq030","article-title":"All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer","volume":"21","author":"Coumans","year":"2010","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"issue":"5","key":"10.1016\/j.neo.2024.101036_bib0032","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/sj.bjc.6602418","article-title":"Detection of circulating epithelial cells in the blood of patients with breast cancer: comparison of three techniques","volume":"92","author":"Ring","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.neo.2024.101036_bib0033","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1541-0420.2008.00995.x","article-title":"Generalized maximally selected statistics","volume":"64","author":"Hothorn","year":"2008","journal-title":"Biometrics"},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0034","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijms23010004","article-title":"Multigene profiling of circulating tumor cells (CTCs) for prognostic assessment in treatment-na\u00efve metastatic hormone-sensitive prostate cancer (mHSPC)","volume":"23","author":"Reichert","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.neo.2024.101036_bib0035","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2174\/138161209788682370","article-title":"The therapeutic potential of ADAM15","volume":"15","author":"Lucas","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"13","key":"10.1016\/j.neo.2024.101036_bib0036","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1158\/1078-0432.CCR-22-0283","article-title":"Molecular pathways and mechanisms of HER2 in cancer therapy","volume":"29","author":"Raghav","year":"2023","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"issue":"3","key":"10.1016\/j.neo.2024.101036_bib0037","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1620\/tjem.185.173","article-title":"Expression of vascular endothelial growth factor gene and its receptor (flt-1) gene in urinary bladder cancer","volume":"185","author":"Sato","year":"1998","journal-title":"Tohoku J. Exp. Med."},{"issue":"6","key":"10.1016\/j.neo.2024.101036_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10060185","article-title":"Cutting to the chase: How matrix metalloproteinase-2 activity controls breast-cancer-to-bone metastasis","volume":"10","author":"Tauro","year":"2018","journal-title":"Cancers"},{"issue":"2","key":"10.1016\/j.neo.2024.101036_bib0039","first-page":"305","article-title":"Overexpression of aldo-keto reductase 1C2 as a high-risk factor in bladder cancer","volume":"17","author":"Tai","year":"2007","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.neo.2024.101036_bib0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3892\/ol.2013.1768","article-title":"Cisplatin resistance by induction of aldo-keto reductase family 1 member C2 in human bladder cancer cells","volume":"7","author":"Shirato","year":"2014","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.neo.2024.101036_bib0041","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41416-018-0034-9","article-title":"In breast cancer subtypes steroid sulfatase (STS) is associated with less aggressive tumour characteristics","volume":"118","author":"McNamara","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.neo.2024.101036_bib0042","first-page":"4463","article-title":"Steroid sulfatase promotes invasion through epithelial\u2011mesenchymal transition and predicts the progression of bladder cancer","volume":"16","author":"Shimizu","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"7","key":"10.1016\/j.neo.2024.101036_bib0043","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrurol.2014.129","article-title":"Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer","volume":"11","author":"Choi","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.neo.2024.101036_bib0044","doi-asserted-by":"crossref","unstructured":"Anon. Disruption of Rb\/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells | cancer research | american association for cancer research [Internet]. [cited 2024 Jun 6]. Available from: https:\/\/aacrjournals.org\/cancerres\/article\/65\/9\/3633\/519684\/Disruption-of-Rb-E2F-Pathway-Results-in-Increased.","DOI":"10.1158\/0008-5472.CAN-04-3129"},{"issue":"6","key":"10.1016\/j.neo.2024.101036_bib0045","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cmet.2021.03.009","article-title":"Creatine promotes cancer metastasis through activation of Smad2\/3","volume":"33","author":"Zhang","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.neo.2024.101036_bib0046","doi-asserted-by":"crossref","DOI":"10.1177\/11769343211049270","article-title":"Exploration of prognostic biomarkers of muscle-invasive bladder cancer (MIBC) by bioinformatics","volume":"17","author":"Xu","year":"2021","journal-title":"Evol. Bioinform."},{"issue":"3","key":"10.1016\/j.neo.2024.101036_bib0047","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/brv.12686","article-title":"Calpain-calpastatin system and cancer progression","volume":"96","author":"Nian","year":"2021","journal-title":"Biol. Rev. Camb. Philos. Soc."},{"issue":"4493","key":"10.1016\/j.neo.2024.101036_bib0048","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1126\/science.7209543","article-title":"Carbamoyl phosphate synthetase (glutamine-hydrolyzing): increased activity in cancer cells","volume":"212","author":"Aoki","year":"1981","journal-title":"Science"},{"issue":"7 July","key":"10.1016\/j.neo.2024.101036_bib0049","first-page":"1","article-title":"Prognostic value of circulating tumor cells in patients with bladder cancer: A meta-analysis","volume":"16","author":"Jiang","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neo.2024.101036_bib0050","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1039\/C9LC01006H","article-title":"Multiparameter urine analysis for quantitative bladder cancer surveillance of orthotopic xenografted mice","volume":"20","author":"Tan","year":"2020","journal-title":"Lab Chip"},{"issue":"24","key":"10.1016\/j.neo.2024.101036_bib0051","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1002\/adma.201600658","article-title":"Tunable thermal-sensitive polymer\u2013graphene oxide composite for efficient capture and release of viable circulating tumor cells","volume":"28","author":"Yoon","year":"2016","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0052","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1186\/1471-2105-12-480","article-title":"GC-content normalization for RNA-Seq data","volume":"12","author":"Risso","year":"2011","journal-title":"BMC Bioinform."},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0053","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1471-2105-11-94","article-title":"Dudoit S. Evaluation of statistical methods for normalization and differential expression in mRNA-Seq experiments","volume":"11","author":"Bullard","year":"2010","journal-title":"BMC Bioinform."},{"issue":"9","key":"10.1016\/j.neo.2024.101036_bib0054","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Dudoit S. Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.neo.2024.101036_bib0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1471-2164-7-115","article-title":"Cell-type specific gene expression profiles of leukocytes in human peripheral blood","volume":"7","author":"Palmer","year":"2006","journal-title":"BMC Genom."},{"issue":"3","key":"10.1016\/j.neo.2024.101036_bib0056","doi-asserted-by":"crossref","first-page":"nwaa180","DOI":"10.1093\/nsr\/nwaa180","article-title":"Single-cell transcriptomic landscape of human blood cells","volume":"8","author":"Xie","year":"2021","journal-title":"Natl. Sci. Rev."},{"issue":"3","key":"10.1016\/j.neo.2024.101036_bib0057","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/biostatistics\/kxr034","article-title":"Using control genes to correct for unwanted variation in microarray data","volume":"13","author":"Gagnon-Bartsch","year":"2012","journal-title":"Biostatistics"},{"issue":"4","key":"10.1016\/j.neo.2024.101036_bib0058","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/bioinformatics\/btu684","article-title":"DOSE: an R\/Bioconductor package for disease ontology semantic and enrichment analysis","volume":"31","author":"Yu","year":"2015","journal-title":"Bioinforma Oxf. Engl."},{"issue":"5","key":"10.1016\/j.neo.2024.101036_bib0059","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS J. Integr. Biol."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624000782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624000782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T03:07:16Z","timestamp":1729220836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558624000782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":59,"alternative-id":["S1476558624000782"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2024.101036","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of circulating tumor cells in patients with metastatic bladder cancer utilizing functionalized microfluidics","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2024.101036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101036"}}